A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increasing allergic reaction among the target population 3.2.1.2 Increasing research and development investments 3.2.1.3 Technological advancements in drug delivery systems 3.2.1.4 Expanding applications beyond allergic reactions 3.2.2 Industry pitfalls & challenges 3.2.2.1 Side effects associated with the medication 3.2.2.2 Stringent regulatory scenario 3.3 Growth potential analysis 3.4 Technological landscape 3.5 Regulatory landscape 3.6 Porter's analysis 3.7 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Competitive positioning matrix 4.4 Strategy outlook matrix Chapter 5 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Tablets 5.3 Capsules 5.4 Injections 5.5 Syrups Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Oral 6.3 Intramuscular Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Histamine-mediated pruritus 7.3 Urticaria 7.4 Atopic contact dermatitis Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Retail pharmacies 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Argentina 9.5.4 Rest of Latin America 9.6 Middle East and Africa 9.6.1 Saudi Arabia 9.6.2 South Africa 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Alliance Pharma Plc 10.2 Amneal Pharmaceuticals, Inc. 10.3 Aurobindo Pharma Limited 10.4 Glenmark Pharmaceuticals Ltd. 10.5 MYLAN N.V. 10.6 Novartis AG 10.7 Pfizer Inc. 10.8 Piramal Enterprises Limited 10.9 Sun Pharmaceutical Industries Limited 10.10 Teva Pharmaceutical Industries Limited
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook